We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Samsung Extends its Medical Device Business in the European Market

By Nadia Liefsoens, MedImaging Regional Director
Posted on 18 Mar 2013
A new medical device brand, called Geo, is showing a company’s commitment to global health through innovative medical devices. More...
The Geo brand includes XGeo for digital radiography, UGeo for ultrasound diagnostic systems, and LabGeo for in vitro diagnostics.

Samsung Electronics Co., Ltd. (Suwon, South Korea) launched its medical brand Geo with Samsung Medison (Gangwon, South Korea) at the European Congress of Radiology (ECR) 2013, held in Vienna (Austria) during March 7-11, 2013. Samsung also presented its latest medical equipment and technologies with Samsung Medison.

“Samsung is committed to bringing a new wave of innovation to the radiology market in Europe with our newly established medical equipment brand,” said S. I. Cho, president and head of the health and medical equipment business at Samsung Electronics and CEO of Samsung Medison. “Samsung will continue to develop products that offer fast, accurate diagnosis to both doctors and patients.

Samsung Electronics’ digital radiography (DR) range provides high performance through panel detectors. Even with dose reduction, XGEeo GC80 still provides effective images and diagnosis, which are both critical for the health and safety of patients. The DR’s soft-handling technology allows users to move the device with low physical pressure even without a side-handle.

The upgraded Accuvix A30 ultrasound system features the single crystal transducer optimized for radiology. The single crystal probe (transducer) provides a wide bandwidth, which allows the user to utilize a wider range of frequencies, granting a better resolution and penetration. Furthermore, for the first time, Samsung Electronics presented portable computed tomography (CT) products from NeuroLogica (Danvers, MA, USA). The company was acquired by Samsung Electronics earlier in 2013.

Moreover, Samsung hosted a satellite symposium at the Congress regarding a new tool for detecting and diagnosing breast cancer, the ultrasound ElastoScan. Speakers discussed the technology within ElastoScan and its diagnostic capability to help detect breast cancer at an early stage and support surgery procedure.

Samsung Electronics Co., Ltd. is a global leader in technology. Samsung Medison is a leading global medical devices company. Founded in 1985, the company markets innovative medical devices including diagnostic ultrasound, digital X-ray, and blood analyzers, in 110 countries worldwide. The company has attracted global attention in the medical field with its R&D capabilities and advanced technologies. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating information technology (IT), image processing, semiconductor and communication technologies into medical devices.

Related Links:

Samsung Electronics
Samsung Medison





Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.